维生素D水平与葡萄膜炎关系研究进展
摘要
关键词
全文:
PDF参考
[1] DANKERS W, COLIN E M, VAN HAMBURG J P, et al. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential[J]. Front Immunol, 2016, 7:697.
[2] HOLICK M F. Vitamin D deficiency[J]. N Engl J Med, 2007, 357(3):266-81.
[3] CARMELIET G, DERMAUW V, BOUILLON R. Vitamin D signaling in calcium and bone homeostasis: a delicate balance[J]. Best Pract Res Clin Endocrinol Metab, 2015, 29(4):621-31.
[4] ANDERSON P H. Vitamin D Activity and Metabolism in Bone[J]. Curr Osteoporos Rep, 2017, 15(5):443-449.
[5] DELUCA H F, CANTORNA M T. Vitamin D: its role and uses in immunology[J]. Faseb j, 2001, 15(14):2579-85.
[6] AKKAYA S, ULUSOY D M. Serum Vitamin D Levels in Patients with Keratoconus[J]. Ocul Immunol Inflamm, 2020, 28(3):348-353.
[7] FERREIRA A, SILVA N, FURTADO M J, et al. Serum vitamin D and age-related macular degeneration: Systematic review and meta-analysis[J]. Surv Ophthalmol, 2021, 66(2):183-197.
[8] HUYNH B, SHAH P, SII F, et al. Low systemic vitamin D as a potential risk factor in primary open-angle glaucoma: a review of current evidence[J]. Br J Ophthalmol, 2021, 105(5):595-601.
[9] ROTHOVA A, SUTTORP-VAN SCHULTEN M S, FRITS TREFFERS W, et al. Causes and frequency of blindness in patients with intraocular inflammatory disease[J]. Br J Ophthalmol, 1996, 80(4):332-6.
[10] BAÑARES A, HERNÁNDEZ-GARCÍA C, FERNÁNDEZ-GUTIÉRREZ B, et al. Eye involvement in the spondyloarthropathies[J]. Rheum Dis Clin North Am, 1998, 24(4):771-84, ix.
[11] JABS D, NUSSENBLATT R, ROSENBAUM J. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop[J]. American journal of ophthalmology, 2005, 140(3):509-16.
[12] CHANG J, WAKEFIELD D. Uveitis: a global perspective[J]. Ocular immunology and inflammation, 2002, 10(4):263-79.
[13] SUTTORP-SCHULTEN M S, ROTHOVA A. The possible impact of uveitis in blindness: a literature survey[J]. Br J Ophthalmol, 1996, 80(9):844-8.
[14] RATHINAM S R, NAMPERUMALSAMY P. Global variation and pattern changes in epidemiology of uveitis[J]. Indian J Ophthalmol, 2007, 55(3):173-83.
[15] D'ALESSANDRO L P, FORSTER D J, RAO N A. Anterior uveitis and hypopyon[J]. Am J Ophthalmol, 1991, 112(3):317-21.
[16] DADACI Z, CETINKAYA S, ONCEL ACIR N, et al. Serum Vitamin D Levels in Patients with Acute Anterior Uveitis[J]. Ocul Immunol Inflamm, 2017, 25(4):492-496.
[17] MITULESCU T, STAVARU C, VOINEA L, et al. The role of Vitamin D in immuno-inflammatory responses in Ankylosing Spondylitis patients with and without Acute Anterior Uveitis[J]. Journal of medicine and life, 2016, 9(1):26-33.
[18] LLOP S M, DAVOUDI S, STANWYCK L K, et al. Association of Low Vitamin D Levels with Noninfectious Uveitis and Scleritis[J]. Ocul Immunol Inflamm, 2019, 27(4):602-609.
[19] CHIU Z K, LIM L L, ROGERS S L, et al. Patterns of Vitamin D Levels and Exposures in Active and Inactive Noninfectious Uveitis Patients[J]. Ophthalmology, 2020, 127(2):230-237.
[20] YI X, YANG P, SUN M, et al. Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease[J]. Mol Vis, 2011, 17:673-9.
Refbacks
- 当前没有refback。